SS 37 - Head and Neck 4: Refining Radiation: What Clinical Trials Can Tell Us

Presentations

• 12:45pm - 12:55pm PT

  A Phase II Trial of Hypofractionated Radiotherapy for Older Adults with Head and Neck Squamous Cell Carcinoma

  Speaker: Daniel Dickstein, MD - Icahn School of Medicine at Mount Sinai, New York
• 12:45pm - 02:00pm PT

  Head and Neck 4: Refining Radiation: What Clinical Trials Can Tell Us

  Speaker: Jennifer De Los Santos, MD, FASTRO - Washington University in St. Louis, St Louis
• 12:45pm - 02:00pm PT

  Head and Neck 4: Refining Radiation: What Clinical Trials Can Tell Us

  Speaker: Dominic Moon, MD - University of Texas Southwestern Medical Center, Dallas
• 12:55pm - 01:05pm PT

  Re-Examining Post-Operative Chemoradiotherapy in Head and Neck Cancer: An Updated Long-Term Combined Analysis of RTOG 9501/EORTC 22931

  Speaker: Zachary Zumsteg, MD - Cedars-Sinai Medical Center, Los Angeles
• 01:05pm - 01:15pm PT

  Osteoradionecrosis as a Complication Following Intensity-Modulated Radiation Therapy or Proton Therapy in the Treatment of Oropharyngeal Carcinoma

  Speaker: Edward Dee, MD - Memorial Sloan Kettering Cancer Center, Middletown Township
• 01:15pm - 01:25pm PT

  Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): A Phase 1 Dose-Escalation Trial of Patients with Xerostomia after Radiation Therapy for Head and Neck Cancer

  Speaker: Grace Blitzer, MD - University of Wisconsin Madison, Madison
• 01:25pm - 01:35pm PT

  High Bleeding Rates in a Randomized Phase 2 Trial of SBRT with Concurrent and Adjuvant Cetuximab +/- Docetaxel in Previously-Irradiated HNSCC

  Speaker: Alberto Vera, MD - UPMC Cancer Center, Pittsburgh
• 01:35pm - 01:45pm PT

  Discussant

  Speaker: Loren Mell, MD, FASTRO - University of California, San Diego, La Jolla